Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: Results of the ALL R-87 protocol

British Journal of Haematology

Volumn 97, Issue 4, 1997, Pages 896-903

  Giona, Fiorina ^a,k   Annino, Luciana ^a   Rondelli, Roberto ^b   Arcese, William ^a   Meloni, Giovanna ^a   Testi, Anna Maria ^a   Moleti, Maria Luisa ^a   Amadori, Sergio ^c   Resegotti, Luigi ^d   Tabilio, Antonio ^e   Ladogana, Saverio ^f   Fioritoni, Giuseppe ^g   Camera, Andrea ^h   Liso, Vincenzo ⁱ   Leoni, Pietro ^j   Mandelli, Franco ^l  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^g Ospedale Civile   (Italy)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ UNIVERSITY OF BARI   (Italy)

^j Ospedale Regionale Torrette   (Italy)

^k Ematologia   (Italy)

^l NONE

more..

Author keywords

Adult ALL; Allogeneic BMT; ID ARAC; Idarubicin; Relapse

Indexed keywords

CYTARABINE; DEXAMETHASONE; FOLINIC ACID; IDARUBICIN; METHOTREXATE; PREDNISONE; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW CELL; CANCER SURVIVAL; CYTOGENETICS; DOSE RESPONSE; FEMALE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; TREATMENT OUTCOME;

EID: 8544280683     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.1102926.x     Document Type: Article

References (13)

1. Arlin, Z.A., Feldman, E., Kempin, S., Ahmed, T., Mittlman, A., Savona, S., Ascensao, J., Baskid, P., Sullivan, P., Fuhr, H.G. & Mertelsmann, R. (1988) Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults. Blood, 72, 433-455.
2. Cox, D.R. (1972) Regression models and life-tables (with discussion). Journal of the Royal Statistical Society (B), 34, 187-220.
3. Freund, M., Diedrich, H., Ganser, A., Gramatzki, M., Heil, G. Heyll, A., Henke, M., Hiddeman, W., Haas, R., Kuse, R., Koch, P., Link, H., Maschmeyer, G., Planker, M., Queiber, W., Schadeck-Gressel, C., Schmidt, N., von Verschuer, U., Williem, S., Thiel, E. & Hoelzer, D. (1992) Treatment of relapsed or refractory adult acute lymophocytic leukemia. Cancer, 69, 709-716.
4. Giona, F., Testi, A.M., Amadori, S., Meloni, G., Carotenuto, M., Resegotti, L., Cotella, R., Leoni, P., Carella, A.M., Grotto, P., Miniero, R. & Mandelli, E. (1990) Idarubicin and high-dose cytarabine in the treatment of refractory and relapsed acute lymphohlastic leukaemia. Annals of Oncology, 1, 51-55.
5. Giona, F., Testi, A.M., Annino, L., Amadori, S., Arcese, W., Camera, A., Cordero di Montezemolo, L., Ladogana, S., Liso, V., Meloni, G., Moleti, M.L., Rondelli, R., Zanesco, L., Pession, A. & Mandelli, F. (1994) Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/ AIEOP experience. British Journal of Haematology, 86, 55-61.
6. Hiddemann, W., Buchner, Th., Heil, G., Schumacher, K., Diedrich, H., Maschmeyer, G., Ho, A.D., Planker, M., Gerith-Stolzenburg, H., Donhuijsen-Ant, R. & Hoelzer, D. (1990) Treatment of refractory acute lymphoblastic leukaemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM). Leukaemia, 4, 637-640.
7. Kantarjan, H.M., Walters, R.L., Keating, M.J., Estey, E.H., O'Brien, S., Schachner, J., McCredie, K. & Freireich, E. (1990) Mitoxantrone and high dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia. Cancer, 65, 5-8.
8. Kaplan, E.L. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
9. Mandelli, F., Annino, L., Vegna, M.L., Camera, A., Ciolli, S., Deplano, W., Fabbiano, F., Ferrara, F., Ladogana, S., Muti, G., Peta, A., Recchia, A., Sica, S., Stasi, R., Tabilio, A., Visani, B. & Baccarani, M. (1992) GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukaemia: preliminary results. Leukaemia, 6, (Suppl. 2), 182-185.
10. Peto, R. & Peto, J. (1972) Asymptotically efficient rank invariant test procedures. Journal of the Royal Statistical Society (A), 135, 185-198.
11. Siegel, S. (1988) Non-parametric Statistics for the Behavioral Sciences, 2nd edn. McGraw-Hill, New York.
12. Tutschka, P.J., Copelan, E.A. & Klein J.P. (1987) Bone marrow transplantation for leukemia following a new busulphan and cyclophosphamide regimen. Blood, 70, 1382-1388.
13. Willemze, R., Peters, W.G., van Hennik, M.B., Fibbe, W.E., Kootte, A.M.M., van Berkel, M., Lie, R., Rodenburg, C.J. & Veltkamp, J.J. (1985) Intermediate- and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma. Scandinavian Journal of Haematology, 34, 83-87.